These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24915402)

  • 41. Antihypertensive effect of angiotensin I-converting enzyme inhibitory peptides from a sesame protein hydrolysate in spontaneously hypertensive rats.
    Nakano D; Ogura K; Miyakoshi M; Ishii F; Kawanishi H; Kurumazuka D; Kwak CJ; Ikemura K; Takaoka M; Moriguchi S; Iino T; Kusumoto A; Asami S; Shibata H; Kiso Y; Matsumura Y
    Biosci Biotechnol Biochem; 2006 May; 70(5):1118-26. PubMed ID: 16717411
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In vitro renin-angiotensin system inhibition and in vivo antihypertensive activity of peptide fractions from lima bean (Phaseolus lunatus L.).
    Ciau-Solís NA; Acevedo-Fernández JJ; Betancur-Ancona D
    J Sci Food Agric; 2018 Jan; 98(2):781-786. PubMed ID: 28707727
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ethanolic Extract of
    Arredondo-Mendoza GI; Jiménez-Salas Z; Garza FJG; Solís-Pérez E; López-Cabanillas-Lomelí M; González-Martínez BE; Campos-Góngora E
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32858788
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiotensin-converting enzyme inhibitors in hypertension: a review.
    Salvetti A; Pedrinelli R; Arzilli F; Abdel-Haq B; Magagna A; Lucarini A; Graziadei L; Nuccorini A; Taddei S
    Int J Clin Pharmacol Res; 1985; 5(6):429-38. PubMed ID: 3005182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Comparison between the effects of angiotensin-converting enzyme inhibitors and angiotensin II antagonists].
    Asmar R; Madonna O; Brisac AM; Benetos A; Laurent S
    Therapie; 1998; 53(3):253-70. PubMed ID: 9773125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiotensin II type 1 receptor antagonist and angiotensin-converting enzyme inhibitor altered the activation of Cu/Zn-containing superoxide dismutase in the heart of stroke-prone spontaneously hypertensive rats.
    Tanaka M; Umemoto S; Kawahara S; Kubo M; Itoh S; Umeji K; Matsuzaki M
    Hypertens Res; 2005 Jan; 28(1):67-77. PubMed ID: 15969257
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood pressure-lowering peptides from neo-fermented buckwheat sprouts: a new approach to estimating ACE-inhibitory activity.
    Koyama M; Hattori S; Amano Y; Watanabe M; Nakamura K
    PLoS One; 2014; 9(9):e105802. PubMed ID: 25222748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Angiotensin II receptor blockade and end-organ protection: pharmacological rationale and evidence.
    Unger T; Culman J; Gohlke P
    J Hypertens Suppl; 1998 Sep; 16(7):S3-9. PubMed ID: 9855025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients.
    Guasti L; Gaudio G; Lupi A; D'Avino M; Sala C; Mugellini A; Vulpis V; Felis S; Sarzani R; Vanasia M; Maffioli P; Derosa G
    Drug Des Devel Ther; 2017; 11():2293-2300. PubMed ID: 28831241
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
    Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
    Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renin-angiotensin-aldosterone system blockade in high-risk hypertensive patients: current approaches and future trends.
    Gullapalli N; Bloch MJ; Basile J
    Ther Adv Cardiovasc Dis; 2010 Dec; 4(6):359-73. PubMed ID: 20965951
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL; Henik RA; Stepien RL
    Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Angiotensin II AT1 receptor antagonists: clinical development and future perspectives].
    Burnier M; Brunner HR
    Therapie; 1998; 53(3):279-84. PubMed ID: 9773127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
    Rao MS
    J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The antihypertensive effects of sodium nitrite are not associated with circulating angiotensin converting enzyme inhibition.
    Pinheiro LC; Amaral JH; Ferreira GC; Montenegro MF; Oliveira-Paula GH; Tanus-Santos JE
    Nitric Oxide; 2014 Aug; 40():52-9. PubMed ID: 24878382
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of the renin-angiotensin-aldosterone system for cerebrorenal protection.
    Lambers Heerspink HJ
    Contrib Nephrol; 2013; 179():7-14. PubMed ID: 23652444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antihypertensive effects of lactoferrin hydrolyzates: Inhibition of angiotensin- and endothelin-converting enzymes.
    Fernández-Musoles R; Salom JB; Martínez-Maqueda D; López-Díez JJ; Recio I; Manzanares P
    Food Chem; 2013 Aug; 139(1-4):994-1000. PubMed ID: 23561201
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination therapy with ACE inhibitors/angiotensin II receptor antagonists and diuretics in hypertension.
    Waeber B
    Expert Rev Cardiovasc Ther; 2003 May; 1(1):43-50. PubMed ID: 15030296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension].
    Burnier M
    Drugs; 2002; 62 Spec No 1():21-9. PubMed ID: 12036386
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is there relationship between the A1166C polymorphism of the angiotensin II receptor AT1 and plasma renin activity, insulin resistance and reduction of blood pressure after angiotensin-converting enzyme inhibitor therapy?
    Głuszek J; Jankowska K
    Pol Arch Med Wewn; 2008 Apr; 118(4):194-200. PubMed ID: 18575418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.